Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma
University of California, San Francisco
University of California, San Francisco
QuantumLeap Healthcare Collaborative
Centre Oscar Lambret
Royal Marsden NHS Foundation Trust
Immune Oncology Research Institute
Centre Leon Berard
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hospices Civils de Lyon
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
Grupo Espanol de Investigacion en Sarcomas
The Netherlands Cancer Institute
Washington University School of Medicine
OHSU Knight Cancer Institute
Herlev and Gentofte Hospital
Fox Chase Cancer Center
Heidelberg University
Brown University
OHSU Knight Cancer Institute
Brown University
Sheffield Teaching Hospitals NHS Foundation Trust
Dong-A University Hospital
National Taiwan University Hospital
UNICANCER
Centre Oscar Lambret
Alliance for Clinical Trials in Oncology
Assistance Publique Hopitaux De Marseille
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of South Florida